Cellectar Biosciences, Inc. Uncategorized Contracts & Agreements

Description of Securities Registered under Section 12(b) of the Securities Exchange Act of 1934 (Filed With SEC on March 9, 2023)

Description of Securities Registered under Section 12(b) of the Securities Exchange Act of 1934 (Filed With SEC on May 10, 2022)

Description of Securities Registered under Section 12(b) of the Securities Exchange Act of 1934 (Filed With SEC on March 2, 2021)

Description of Securities Registered under Section 12(b) of the Securities Exchange Act of 1934 (Filed With SEC on March 9, 2020)

Offer Letter between the Company and Brian Posner dated April 1, 2018 (Filed With SEC on April 4, 2018)

Incorporated under the laws of the Stateof Delaware, June 24, 1996 (Filed With SEC on November 18, 2016)

[SIGNATURES ON THE FOLLOWINGPAGE] (Filed With SEC on April 14, 2016)

PLACEMENTAGENCY AGREEMENT (Filed With SEC on September 30, 2015)

SECURITIESPURCHASE AGREEMENT (Filed With SEC on September 30, 2015)

CONSENT AGREEMENT (Filed With SEC on August 4, 2014)

UNDERWRITINGAGREEMENT between CELLECTARBIOSCIENCES, INC. and AEGIS CAPITALCORP., as Representativeof the Several Underwriters (Filed With SEC on July 7, 2014)

EXECUTIVERETENTION AGREEMENT (Filed With SEC on November 13, 2013)

SECURITIESPURCHASE AGREEMENT (Filed With SEC on February 14, 2013)

SECURITIESPURCHASE AGREEMENT (Filed With SEC on November 20, 2012)

SECURITIESPURCHASE AGREEMENT (Filed With SEC on June 11, 2012)

SECURITIESPURCHASE AGREEMENT (Filed With SEC on June 6, 2012)

SECURITIESPURCHASE AGREEMENT (Filed With SEC on May 14, 2012)

AMENDMENT AGREEMENT (Filed With SEC on May 14, 2012)

Rodman & Renshaw,LLC 1251 Avenue of the Americas, 20th Floor, New York, NY 10020 Tel: 212356 0500 Fax: 212 581 5690 www.rodm.com Member: FINRA, SIPC (Filed With SEC on April 9, 2012)

SECURITIESPURCHASE AGREEMENT (Filed With SEC on July 22, 2010)

SECURITIESPURCHASE AGREEMENT (Filed With SEC on July 7, 2010)

EXECUTIVERETENTION AGREEMENT (Filed With SEC on May 17, 2010)

CONSENT AND AMENDMENTAGREEMENT (Filed With SEC on January 26, 2010)

SECURITIES PURCHASEAGREEMENT (Filed With SEC on September 15, 2009)

REGISTRATION RIGHTSAGREEMENT (Filed With SEC on September 15, 2009)

LP CloverLimited Par LaVille Place 14Par-La-Ville Road P.O. BoxHM 2332 HamiltonHM JX, Bermuda (Filed With SEC on September 15, 2009)

MundipharmaInternational Corporation Limited Par LaVille Place 14Par-La-Ville Road P.O. BoxHM 2332 HamiltonHM JX, Bermuda (Filed With SEC on September 15, 2009)

CERTIFICATEOF ELIMINATION (Filed With SEC on February 18, 2009)

SECURITIES PURCHASEAGREEMENT (Filed With SEC on February 18, 2009)

REGISTRATION RIGHTSAGREEMENT (Filed With SEC on February 18, 2009)

WARRANTAMENDMENT AGREEMENT (Filed With SEC on February 18, 2009)

NOVELOS THERAPEUTICS ELECTS DR. STEPHEN HILL TO SERVE AS CHAIRMAN OF BOARD OF DIRECTORS (Filed With SEC on September 19, 2007)

NOVELOS THERAPEUTICS APPOINTS DR. JAMES MANUSO TO BOARD OF DIRECTORS (Filed With SEC on August 15, 2007)